The diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults

References

• Polanczyk G, De Lima MS, Horta BL, et al. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942–948. doi: 10.1176/ajp.2007.164.6.942
   PubMed Web of Science ®Google Scholar
• Simon V, Czobor P, Bálint S, et al. Prevalence and correlates of adult attention-deficit hyperactivity disorder: meta-analysis. Br J Psychiatry. 2009;194(3):204–211. doi: 10.1192/bjp.bp.107.048827
   PubMed Web of Science ®Google Scholar
• Faraone SV, Asherson P, Banaschewski T, et al. Attention-deficit/hyperactivity disorder [article]. Nat Rev Dis Primers. 2015;1(1):1. doi: 10.1038/nrdp.2015.20
   Google Scholar
• Brikell I, Kuja-Halkola R, Larsson H. Heritability of attention-deficit hyperactivity disorder in adults. Am J Med Genet B Neuropsychiatr Genet. 2015 Sep;168(6):406–413. doi: 10.1002/ajmg.b.32335
   PubMed Web of Science ®Google Scholar
• Kooij JJS, Michielsen M, Kruithof H, et al. ADHD in old age: a review of the literature and proposal for assessment and treatment. Expert Rev Neurotherapeutics. 2016;16(12):1371–1381. doi: 10.1080/14737175.2016.1204914.
   PubMed Web of Science ®Google Scholar
• Torgersen T, Gjervan B, Lensing MB, et al. Optimal management of ADHD in older adults. Neuropsychiatric disease and treatment. Neuropsychiatr Dis Treat. 2016:79. doi: 10.2147/NDT.S59271.
   PubMedGoogle Scholar
• Goodman DW, Mitchell S, Rhodewalt L, et al. Clinical presentation, diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults: a review of the evidence and its implications for clinical care. Drugs Aging. 2016;33(1):27–36. doi: 10.1007/s40266-015-0327-0.
   PubMed Web of Science ®Google Scholar
• Dobrosavljevic M, Solares C, Cortese S, et al. Prevalence of attention-deficit/hyperactivity disorder in older adults: A systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews. 2020;118:282–28.
   PubMed Web of Science ®Google Scholar
• He W, Goodkind D, Kowal PR. An aging world: 2015. (WA), DC: United States Census Bureau; 2016.
   Google Scholar
• Franke B, Michelini G, Asherson P, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol. 2018 Oct;28(10):1059–1088. doi: 10.1016/j.euroneuro.2018.08.001
   PubMed Web of Science ®Google Scholar
• Sobanski E. Psychiatric comorbidity in adults with attention-deficit/hyperactivity disorder (ADHD). Eur Arch Psychiatry Clin Neurosci. 2006;256(S1):i26–i31. doi: 10.1007/s00406-006-1004-4
   PubMed Web of Science ®Google Scholar
• Kittel-Schneider S, Arteaga-Henriquez G, Vasquez AA, et al. Non-mental diseases associated with ADHD across the lifespan: fidgety philipp and pippi longstocking at risk of multimorbidity? Neuroscience & Biobehavioral Reviews. 2022;132:1157–1180. doi: 10.1016/j.neubiorev.2021.10.035
   PubMed Web of Science ®Google Scholar
• Fayyad J, Sampson NA, Hwang I, et al. The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys. Atten Def Hyp Disord. 2017;9(1):47–65. doi: 10.1007/s12402-016-0208-3
   PubMedGoogle Scholar
• Thomas R, Sanders S, Doust J, et al. Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. Pediatrics. 2015;135(4):e994–e1001. doi: 10.1542/peds.2014-3482
   PubMed Web of Science ®Google Scholar
• Biederman J, Petty CR, Evans M, et al. How persistent is ADHD? A controlled 10-year follow-up study of boys with ADHD. Psychiatry Res. 2010;177(3):299–304. doi: 10.1016/j.psychres.2009.12.010
   PubMed Web of Science ®Google Scholar
• Barkley RA, Fischer M, Smallish L, et al. The persistence of attention-deficit/hyperactivity disorder into young adulthood as a function of reporting source and definition of disorder. J Abnorm Psychol. 2002 May;111(2):279–289. doi: 10.1037/0021-843X.111.2.279
   PubMed Web of Science ®Google Scholar
• Hart EL, Lahey BB, Loeber R, et al. Developmental change in attention-deficit hyperactivity disorder in boys: a four-year longitudinal study. J Abnorm Child Psychol. 1995 Dec;23(6):729–749. doi: 10.1007/BF01447474
   PubMed Web of Science ®Google Scholar
• Caye A, Swanson J, Thapar A, et al. Life span studies of ADHD-Conceptual challenges and predictors of persistence and outcome. Curr Psychiatry Rep. 2016 Dec;18(12):111. doi: 10.1007/s11920-016-0750-x
   PubMed Web of Science ®Google Scholar
• Moffitt TE, Houts R, Asherson P, et al. Is adult ADHD a childhood-onset neurodevelopmental disorder? Evidence from a four-decade longitudinal cohort study. Am J Psychiatry. 2015;172(10):967–977. doi: 10.1176/appi.ajp.2015.14101266
   PubMed Web of Science ®Google Scholar
• Thorell LB, Holst Y, Sjöwall D. Quality of life in older adults with ADHD: links to ADHD symptom levels and executive functioning deficits. Nord J Psychiatry. 2019;73(7):409–416. doi: 10.1080/08039488.2019.1646804
   PubMed Web of Science ®Google Scholar
• de Zwaan M, Gruß B, Müller A, et al. The estimated prevalence and correlates of adult ADHD in a German community sample. Eur Arch Psychiatry Clin Neurosci. 2012;262(1):79–86. doi: 10.1007/s00406-011-0211-9
   PubMed Web of Science ®Google Scholar
• Guldberg-Kjär T, Sehlin S, Johansson B. ADHD symptoms across the lifespan in a population-based Swedish sample aged 65 to 80. Int Psychogeriatr. 2013;25(4):667–675. doi: 10.1017/S1041610212002050
   PubMed Web of Science ®Google Scholar
• Bernardi S, Faraone SV, Cortese S, et al. The lifetime impact of attention deficit hyperactivity disorder: results from the National Epidemiologic survey on Alcohol and related conditions (NESARC). Psychol Med. 2012 Apr;42(4):875–887. doi: 10.1017/S003329171100153X
   PubMed Web of Science ®Google Scholar
• Kooij JJ, Buitelaar JK, van den Oord EJ, et al. Internal and external validity of attention-deficit hyperactivity disorder in a population-based sample of adults. Psychological Medicine. 2005;35(6):817–827. doi: 10.1017/S003329170400337X
   PubMed Web of Science ®Google Scholar
• Nigg JT. Attention-deficit/hyperactivity disorder and adverse health outcomes. Clin Psychol Rev. 2013;33(2):215–228. doi: 10.1016/j.cpr.2012.11.005
   PubMed Web of Science ®Google Scholar
• Semeijn EJ, Korten NCM, Comijs HC, et al. No lower cognitive functioning in older adults with attention-deficit/hyperactivity disorder. Int Psychogeriatr. 2015;27(9):1467–1476. doi: 10.1017/S1041610215000010
   PubMed Web of Science ®Google Scholar
• Brod M, Schmitt E, Goodwin M, et al. ADHD burden of illness in older adults: a life course perspective. Qual Life Res. 2012 Jun;21(5):795–799. doi: 10.1007/s11136-011-9981-9
   PubMed Web of Science ®Google Scholar
• Michielsen M, de Kruif J, Comijs HC, et al. The burden of ADHD in older adults: a qualitative study. J Atten Disord. 2018 Apr;22(6):591–600. doi: 10.1177/1087054715610001
   PubMed Web of Science ®Google Scholar
• Michielsen M, Comijs HC, Aartsen MJ, et al. The relationships between ADHD and social functioning and participation in older adults in a population-based study. J Atten Disord. 2015;19(5):368–379. doi: 10.1177/1087054713515748
   PubMed Web of Science ®Google Scholar
• Lensing MB, Zeiner P, Sandvik L, et al. Quality of life in adults aged 50+ with ADHD. J Atten Disord. 2015 May;19(5):405–413. doi: 10.1177/1087054713480035
   PubMed Web of Science ®Google Scholar
• Instanes JT, Klungsøyr K, Halmøy A, et al. Adult ADHD and comorbid somatic disease: a systematic literature review. J Atten Disord. 2018;22(3):203–228. doi: 10.1177/1087054716669589
   PubMed Web of Science ®Google Scholar
• Hartman CA, Larsson H, Vos M, et al. Anxiety, mood, and substance use disorders in adult men and women with and without attention-deficit/hyperactivity disorder: a substantive and methodological overview. Neurosci Biobehav Rev. 2023;151:105209. doi: 10.1016/j.neubiorev.2023.105209
   PubMed Web of Science ®Google Scholar
• Müller M, Turner D, Barra S, et al. ADHD and associated psychopathology in older adults in a German community sample. J Neural Transm (Vienna). 2023 Mar;130(3):313–323. doi: 10.1007/s00702-022-02584-4
   PubMed Web of Science ®Google Scholar
• Michielsen M, Comijs HC, Semeijn EJ, et al. The comorbidity of anxiety and depressive symptoms in older adults with attention-deficit/hyperactivity disorder: a longitudinal study. J Affective Disorders. 2013;148(2):220–227. doi: 10.1016/j.jad.2012.11.063
   PubMed Web of Science ®Google Scholar
• Dalsgaard S, Østergaard SD, Leckman JF, et al. Mortality in children, adolescents, and adults with attention deficit hyperactivity disorder: a nationwide cohort study. Lancet. 2015 May 30;385(9983):2190–2196. doi: 10.1016/S0140-6736(14)61684-6
   PubMed Web of Science ®Google Scholar
• Stickley A, Koyanagi A, Takahashi H, et al. Attention-deficit/hyperactivity disorder and physical multimorbidity: a population-based study. Eur Psychiatry. 2017;45:227–234.37. doi: 10.1016/j.eurpsy.2017.07.010
   PubMed Web of Science ®Google Scholar
• Li L, Yao H, Zhang L, et al. Attention-deficit/hyperactivity disorder is associated with increased risk of cardiovascular diseases: a systematic review and meta-analysis. JCPP Advances. 2023:e12158. doi:10.1002/jcv2.12158
   PubMedGoogle Scholar
• Semeijn EJ, Sandra Kooij JJ, Comijs HC, et al. Attention-deficit/Hyperactivity disorder, physical health, and lifestyle in older adults. J Am Geriatr Soc. 2013;61(6):882–887. doi: 10.1111/jgs.12261
   PubMed Web of Science ®Google Scholar
• Tzeng N-S, Chung C-H, Lin F-H, et al. Risk of dementia in adults with ADHD: a nationwide, population-based cohort study in Taiwan. J Atten Disord. 2019;23(9):995–1006. doi: 10.1177/1087054717714057
   PubMed Web of Science ®Google Scholar
• Golimstok A, Rojas JI, Romano M, et al. Previous adult attention-deficit and hyperactivity disorder symptoms and risk of dementia with Lewy bodies: a case–control study. Eur J Neurol. 2011;18(1):78–84. doi: 10.1111/j.1468-1331.2010.03064.x
   PubMed Web of Science ®Google Scholar
• Fluegge K, Fluegge K. Antecedent ADHD, dementia, and metabolic dysregulation: a U.S. based cohort analysis. Neurochem Int. 2018;112:255–258. doi: 10.1016/j.neuint.2017.08.005
   PubMed Web of Science ®Google Scholar
• Dobrosavljevic M, Zhang L, Garcia-Argibay M, et al. Attention-deficit/hyperactivity disorder as a risk factor for dementia and mild cognitive impairment: a population-based register study. Eur Psychiatry. 2022;65(1):e3.43. doi: 10.1192/j.eurpsy.2021.2261
   Web of Science ®Google Scholar
• Demontis D, Walters RK, Martin J, et al. Discovery of the first genome-wide significant risk loci for attention deficit/hyperactivity disorder. Nature Genet. 2019;51(1):63–75. doi: 10.1038/s41588-018-0269-7
   PubMed Web of Science ®Google Scholar
• Demontis D, Walters GB, Athanasiadis G, et al. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genet. 2023;55(2):198–208. doi: 10.1038/s41588-022-01285-8
   PubMedGoogle Scholar
• Zhang L, Du Rietz E, Kuja-Halkola R, et al. Attention-deficit/hyperactivity disorder and Alzheimer’s disease and any dementia: a multi-generation cohort study in Sweden. Alzheimer’s Dementia. 2022;18(6):1155–1163. doi: 10.1002/alz.12462
   PubMed Web of Science ®Google Scholar
• Pettersson E, Larsson H, Lichtenstein P. Common psychiatric disorders share the same genetic origin: a multivariate sibling study of the Swedish population. Mol Psychiatry. 2016 May;21(5):717–721. doi: 10.1038/mp.2015.116
   PubMed Web of Science ®Google Scholar
• Du Rietz E, Brikell I, Butwicka A, et al. Mapping phenotypic and aetiological associations between ADHD and physical conditions in adulthood in Sweden: a genetically informed register study. Lancet Psychiatry. 2021;8(9):774–783. doi: 10.1016/S2215-0366(21)00171-1
   PubMedGoogle Scholar
• Li L, Chang Z, Sun J, et al. Attention‐deficit/hyperactivity disorder as a risk factor for cardiovascular diseases: a nationwide population‐based cohort study. World Psychiatry. 2022;21(3):452–459. doi: 10.1002/wps.21020
   PubMed Web of Science ®Google Scholar
• Xu G, Snetselaar LG, Strathearn L, et al. Association between history of attention-deficit/hyperactivity disorder diagnosis and cardiovascular disease in U.S. adults. Health Psychol. 2022 Oct;41(10):693–700. doi: 10.1037/hea0001193
   PubMed Web of Science ®Google Scholar
• Garcia-Argibay M, du Rietz E, Lu Y, et al. The role of ADHD genetic risk in mid-to-late life somatic health conditions. Transl Psychiatry. 2022;12(1):152. doi: 10.1038/s41398-022-01919-9
   PubMed Web of Science ®Google Scholar
• Das D, Cherbuin N, Easteal S, et al. Attention deficit/hyperactivity disorder symptoms and cognitive abilities in the late-life cohort of the PATH through life study. PLoS One. 2014;9(1):e86552.52. doi: 10.1371/journal.pone.0086552
   Web of Science ®Google Scholar
• World Health Organization . International statistical classification of diseases and related health problems, Eleventh Revision (ICD-11). 2019. Accessed 1 May, 2023. https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/821852937
   Google Scholar
• American Psychiatric Association. Diagnostic and Statistical manual of Mental disorders. 5th ed. 2022. text rev. doi: 10.1176/appi.books.9780890425787
   Google Scholar
• Epstein JN, Loren RE. Changes in the definition of ADHD in DSM-5: subtle but important. Neuropsychiatry. 2013 Oct 1;3(5):455–458. doi: 10.2217/npy.13.59
   PubMedGoogle Scholar
• Kooij JJS, Bijlenga D, Salerno L, et al. Updated European consensus statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019 Feb;56(1):14–34. doi: 10.1016/j.eurpsy.2018.11.001.
   PubMedGoogle Scholar
• Kessler RC, Adler L, Ames M, et al. The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychological Medicine. 2005;35(2):245–256. doi: 10.1017/S0033291704002892
   PubMed Web of Science ®Google Scholar
• Ustun B, Adler LA, Rudin C, et al. The World Health Organization adult attention-deficit/hyperactivity disorder self-report screening scale for DSM-5. JAMA Psychiatry. 2017;74(5):520–526. doi: 10.1001/jamapsychiatry.2017.0298
   PubMed Web of Science ®Google Scholar
• Kooij J, Francken M, Bron T, et al. Diagnostic interview for ADHD in adults (DIVA). Hague: DIVA Foundation; 2010.
   Google Scholar
• Ramos-Quiroga JA, Bosch R, Richarte V, et al. Criterion and concurrent validity of Conners adult ADHD diagnostic interview for DSM-IV (CAADID) Spanish version. Rev Psiquiatr Salud Ment. 2012;5(4):229–235. doi: 10.1016/j.rpsmen.2012.05.002
   PubMed Web of Science ®Google Scholar
• Barkley RA, Murphy KR, Fischer M. ADHD in adults: what the science says. New York, NY: Guilford press; 2010.
   Google Scholar
• Semeijn EJ, Michielsen M, Comijs HC, et al. Criterion validity of an attention deficit hyperactivity disorder (ADHD) screening list for screening ADHD in older adults aged 60–94 years. Am J Geriatric Psychiatry. 2013;21(7):631–635. doi: 10.1016/j.jagp.2012.08.003.
   PubMed Web of Science ®Google Scholar
• Callahan BL, Bierstone D, Stuss DT, et al. Adult ADHD: risk factor for dementia or phenotypic mimic? Front Aging Neurosci. 2017;9:260. doi: 10.3389/fnagi.2017.00260
   PubMed Web of Science ®Google Scholar
• Brodaty H, Connors MH. Pseudodementia, pseudo-pseudodementia, and pseudodepression. Alzheimer’s Dement: Diagn Assess Dis Monit. 2020;12(1):e12027. doi: 10.1002/dad2.12027
   PubMedGoogle Scholar
• Fried TR, O’Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc. 2014 Dec;62(12):2261–2272. doi: 10.1111/jgs.13153
   PubMed Web of Science ®Google Scholar
• Pollak J. Distinguishing between adult ADHD and mild cognitive impairment. Curr Psychiatry. 2012;11(8):48–50.
   Google Scholar
• Pessoa RMP, Bomfim AJL, Ferreira BLC, et al. Diagnostic criteria and prevalence of mild cognitive impairment in older adults living in the community: a systematic review and meta-analysis. Arch Clin Psychiatry. 2019;46(3):72–79. doi: 10.1590/0101-60830000000197
   Web of Science ®Google Scholar
• Chen P, Cai H, Bai W, et al. Global prevalence of mild cognitive impairment among older adults living in nursing homes: a meta-analysis and systematic review of epidemiological surveys. Transl Psychiatry. 2023;13(1):88. doi: 10.1038/s41398-023-02361-1
   PubMed Web of Science ®Google Scholar
• Surman CB, Goodman DW. Is ADHD a valid diagnosis in older adults? Atten Def Hyp Disord. 2017;9:161–168. doi: 10.1007/s12402-017-0217-x
   PubMedGoogle Scholar
• Sharma MJ, Lavoie S, Callahan BL. A call for research on the validity of the age-of-onset criterion application in older adults being evaluated for ADHD: a review of the literature in clinical and cognitive psychology. Am J Geriatric Psychiatry. 2021;29(7):669–678. doi: 10.1016/j.jagp.2020.10.016
   PubMed Web of Science ®Google Scholar
• Fischer BL, Gunter-Hunt G, Steinhafel CH, et al. The identification and assessment of late-life ADHD in memory clinics. J Atten Disord. 2012;16(4):333–338. doi: 10.1177/1087054711398886
   PubMed Web of Science ®Google Scholar
• Hyman IE, Loftus EF. Errors in autobiographical memory. Clin Psychol Rev. 1998;18(8):933–947. doi: 10.1016/S0272-7358(98)00041-5
   PubMed Web of Science ®Google Scholar
• Hervey AS, Epstein JN, Curry JF. Neuropsychology of adults with attention-deficit/Hyperactivity disorder: a meta-analytic review. Neuropsychology. 2004;18(3):485–503. doi: 10.1037/0894-4105.18.3.485
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R, et al. The prevalence and correlates of adult ADHD in the United States: results from the national comorbidity survey replication. Am J Psychiatry. 2006 Apr;163(4):716–723. doi: 10.1176/ajp.2006.163.4.716
   PubMed Web of Science ®Google Scholar
• Kieling C, Kieling RR, Rohde LA, et al. The age at onset of attention deficit hyperactivity disorder. Am J Psychiatry. 2010;167(1):14–16. doi: 10.1176/appi.ajp.2009.09060796
   PubMed Web of Science ®Google Scholar
• Sibley MH, Rohde LA, Swanson JM, et al. Late-onset ADHD reconsidered with comprehensive repeated assessments between ages 10 and 25. Am J Psychiatry. 2018;175(2):140–149. doi: 10.1176/appi.ajp.2017.17030298
   PubMed Web of Science ®Google Scholar
• Castle L, Aubert RE, Verbrugge RR, et al. Trends in medication treatment for ADHD. J Atten Disord. 2007;10(4):335–342. doi: 10.1177/1087054707299597
   PubMedGoogle Scholar
• McCarthy S, Wilton L, Murray ML, et al. The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in children, adolescents and adults in UK primary care. BMC Pediatr. 2012;12(1):78. doi: 10.1186/1471-2431-12-78
   PubMedGoogle Scholar
• Huang C-C, Chu C-C, Cheng T-J, et al. Epidemiology of treated attention-deficit/Hyperactivity disorder (ADHD) across the lifespan in Taiwan: a nationwide population-based longitudinal study. PLoS One. 2014;9(4):e95014. doi: 10.1371/journal.pone.0095014
   PubMed Web of Science ®Google Scholar
• Ormhøj SS, Pottegård A, Gasse C, et al. Use of attention‐deficit/hyperactivity disorder medication among older adults in Denmark. Br J Clin Pharmacol. 2018;84(7):1505–1513. doi: 10.1111/bcp.13569
   PubMed Web of Science ®Google Scholar
• Polyzoi M, Ahnemark E, Medin E, et al. Estimated prevalence and incidence of diagnosed ADHD and health care utilization in adults in Sweden – a longitudinal population-based register study. Neuropsychiatr Dis Treat. 2018;14:1149–1161. doi: 10.2147/NDT.S155838
   PubMed Web of Science ®Google Scholar
• Karlstad Ø, Zoëga H, Furu K et al . Use of drugs for ADHD among adults—a multinational study among 15.8 million adults in the Nordic countries. Eur J Clin Pharmacol. 2016;72(12):1507–1514. doi:10.1007/s00228-016-2125-y.
   PubMed Web of Science ®Google Scholar
• Lensing MB, Zeiner P, Sandvik L, et al. Psychopharmacological treatment of ADHD in adults aged 50+ an empirical study. J Atten Disord. 2015;19(5):380–389. doi: 10.1177/1087054714527342.
   PubMed Web of Science ®Google Scholar
• Michielsen M, Kleef D, Bijlenga D, et al. Response and side effects using stimulant medication in older adults with ADHD: an observational archive study. J Atten Disord. 2021;25(12):1712–1719. doi: 10.1177/1087054720925884.
   PubMed Web of Science ®Google Scholar
• Manor I, Rozen S, Zemishlani Z, et al. When does it end? attention-deficit/hyperactivity disorder in the middle aged and older populations. Clin Neuropharmacol. 2011 Jul;34(4):148–154. doi: 10.1097/WNF.0b013e3182206dc1
   PubMed Web of Science ®Google Scholar
• Durell T, Adler L, Wilens T, et al. Atomoxetine treatment for ADHD: younger adults compared with older adults. J Atten Disord. 2010 Jan;13(4):401–406. doi: 10.1177/1087054709342203
   PubMed Web of Science ®Google Scholar
• Ermer J, Haffey MB, Richards C, et al. Double-blind, placebo-controlled, two-period, crossover trial to examine the pharmacokinetics of lisdexamfetamine dimesylate in healthy older adults. Neuropsychiatr Dis Treat. 2013;9:219–229. doi: 10.2147/NDT.S38377
   PubMed Web of Science ®Google Scholar
• Sassi KLM, Rocha NP, Colpo GD, et al. Amphetamine use in the elderly: a systematic review of the literature. Curr Neuropharmacol. 2020;18(2):126–135. doi: 10.2174/1570159X17666191010093021
   PubMed Web of Science ®Google Scholar
• National Institute for Health and Care Excellence: Guidelines, in Attention deficit hyperactivity disorder: diagnosis and management. 2019. London: National Institute for Health and Care Excellence (NICE) Copyright © NICE 2018.
   Google Scholar
• CADDRA. Canadian ADHD Resource Alliance: Canadian ADHD Practice guidelines. 4.1 Edition ed. Toronto ON: CADDRA; 2020.
   Google Scholar
• Interdisciplinary evidence-and consensus-based (S3) Guideline “attention deficit/hyperactivity disorder in children, young people and adults”[in German]. 2018. Available from: https://www.awmf.org/uploads/tx_szleitlinien/028-045l_S3_ADHS_2018-06.pdf.
   Google Scholar
• Clinical Practice Guideline on Therapeutic Interventions in Attention Deficit Hyperactivity Disorder (ADHD). Ministry of Health, Social Services and Equality. Health Sciences Institute in Aragon (IACS) [in Spanish]. 2017.
   Google Scholar
• Royal College of Psychiatrists in Scotland, ADHD in adults: good practice guidelines 2017.
   Google Scholar
• EMA, Guideline on the clinical investigation of medicinal products for the treatment of attention deficit hyperactivity disorder (ADHD). 2008.
   Google Scholar
• Chappuy M, Boulanger A, Nourredine M, et al. Disparate regulatory status of methylphenidate for adults with ADHD across Europe. Lancet Psychiatry. 2020 Jan;7(1):e1–e2. doi: 10.1016/S2215-0366(19)30482-1
   PubMed Web of Science ®Google Scholar
• HAS - Evaluation and access to innovation department, methylphenidate RITALIN LP 10 mg, 20 mg, 30 mg and 40 mg prolonged-release hard capsules. New Indication TRANSPARENCY COMMITTEE SUMMARY 17 NOVEMBER 2021. Available from: https://www.has-sante.fr/upload/docs/application/pdf/2022-03/ritaline_lp_171121_summary_ct19405.pdf
   Google Scholar
• Nasser A, Hull JT, Chaturvedi SA, et al. A phase III, randomized, Double-blind, placebo-controlled trial assessing the efficacy and safety of Viloxazine Extended-release Capsules in adults with attention-deficit/Hyperactivity disorder. CNS Drugs. 2022 Aug;36(8):897–915. doi: 10.1007/s40263-022-00938-w
   PubMed Web of Science ®Google Scholar
• Dobrosavljevic M, Seena F, Ebba Du R, et al. Risk prediction model for cardiovascular diseases in adults initiating pharmacological treatment for attention-deficit/hyperactivity disorder. Evid Based Mental Health. 2022;25(4):185. doi: 10.1136/ebmental-2022-300492
   PubMed Web of Science ®Google Scholar